Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zi-Zhen Xu, Jian-Kang Shen, Shu-Qing Zhao & Jun-Min Li. (2018) Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 59:6, pages 1451-1460.
Read now
Read now
Articles from other publishers (29)
Rui Liang & Guanbin Song. (2023) Matrix stiffness-driven cancer progression and the targeted therapeutic strategy. Mechanobiology in Medicine 1:2, pages 100013.
Crossref
Crossref
Micah N. Sagini, Michael Zepp, Ergül Eyol, Doaa M. Ali, Svetlana Gromova, Mathias Dahlmann, Diana Behrens, Christian Groeschel, Linus Tischmeier, Jens Hoffmann, Martin R. Berger & Wolf-Georg Forssmann. (2023) EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models. Peptides, pages 171111.
Crossref
Crossref
Yu Nie, Xiaoya Yun, Ya Zhang & Xin Wang. (2022) Targeting metabolic reprogramming in chronic lymphocytic leukemia. Experimental Hematology & Oncology 11:1.
Crossref
Crossref
Katarzyna Szklener, Adam Michalski, Klaudia Żak, Michał Piwoński & Sławomir Mańdziuk. (2022) Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions. Cells 11:8, pages 1338.
Crossref
Crossref
Simone A. Brysland, Muhammad Gohar Maqbool, Dipti Talaulikar & Elizabeth E. Gardiner. 2022.
Md. Hasan Tarek, Md. Eusha Kadir, Sadia Sharmin, Abu Ashfaqur Sajib, Amin Ahsan Ali & Mohammad Shoyaib. (2021) Feature Subset Selection based on Redundancy Maximized Clusters. Feature Subset Selection based on Redundancy Maximized Clusters.
Luisa Gaydou, Ma Florencia Rossetti, Ma Virginia Tschopp, Cora Stoker, Verónica L. Bosquiazzo & Jorge G. Ramos. (2020) Epigenetic regulation of steroidogenic enzymes expressed in peripheral blood mononuclear cells from healthy individuals and from patients with chronic lymphocytic leukemia. The Journal of Steroid Biochemistry and Molecular Biology 204, pages 105767.
Crossref
Crossref
Laura Patrussi, Nagaja Capitani & Cosima T. Baldari. (2019) Abnormalities in chemokine receptor recycling in chronic lymphocytic leukemia. Cellular and Molecular Life Sciences 76:16, pages 3249-3261.
Crossref
Crossref
Melody R. Becnel, Loretta J. Nastoupil, Felipe Samaniego, Richard E. Davis, M. J. You, Michael Green, Fredrick B. Hagemeister, Michelle A. Fanale, Luis E. Fayad, Jason R. Westin, Michael Wang, Yasuhiro Oki, Sheryl G. Forbes, Lei Feng, Sattva S. Neelapu & Nathan H. Fowler. (2019)
Lenalidomide plus rituximab (R
2
) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial
. British Journal of Haematology 185:5, pages 874-882.
Crossref
Crossref
Lauren A. Thurgood, Eveline S. Dwyer, Karen M. Lower, Tim K. Chataway & Bryone J. Kuss. (2019)
Altered expression of metabolic pathways in
CLL
detected by unlabelled quantitative mass spectrometry analysis
. British Journal of Haematology 185:1, pages 65-78.
Crossref
Crossref
Hui Du, Li Zhang, Guangyao Li, Wei Liu, Wenqiang Tang, Hangfan Zhang, Jing Luan, Lei Gao & Xin Wang. (2019) CXCR4 and CCR7 Expression in Primary Nodal Diffuse Large B-Cell Lymphoma—A Clinical and Immunohistochemical Study. The American Journal of the Medical Sciences 357:4, pages 302-310.
Crossref
Crossref
Hui Du, Lei Gao, Jing Luan, Hangfan Zhang & Taiwu Xiao. (2019) C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges. Acta Haematologica 142:2, pages 64-70.
Crossref
Crossref
Gerardo Ferrer & Emili Montserrat. (2018) Critical molecular pathways in CLL therapy. Molecular Medicine 24:1.
Crossref
Crossref
Alessio Montresor, Lara Toffali, Antonella Rigo, Isacco Ferrarini, Fabrizio Vinante & Carlo Laudanna. (2018) CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton’s tyrosine kinase. Oncotarget 9:80, pages 35123-35140.
Crossref
Crossref
Melody R. Becnel & Loretta J. Nastoupil. (2018) Follicular Lymphoma: Past, Present, and Future. Current Treatment Options in Oncology 19:7.
Crossref
Crossref
Mustafa A. Barbhuiya, Manoj K. Kashyap, Vinuth N. Puttamallesh, Rekha Vijay Kumar, Xinyan Wu, Akhilesh Pandey & Harsha Gowda. (2018) Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays. Oncotarget 9:26, pages 18422-18434.
Crossref
Crossref
Eduardo Vadillo, Elisa Dorantes-Acosta, Rosana Pelayo & Michael Schnoor. (2018) T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies. Blood Reviews 32:1, pages 36-51.
Crossref
Crossref
Monika Podhorecka, Aneta Goracy, Agnieszka Szymczyk, Malgorzata Kowal, Blanca Ibanez, Olga Jankowska-Lecka, Arkadiusz Macheta, Aleksandra Nowaczynska, Elzbieta Drab-Urbanek, Sylwia Chocholska, Dariusz Jawniak & Marek Hus. (2017) Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number. Oncotarget 8:21, pages 34661-34669.
Crossref
Crossref
Jia-Chi Ma, Xiao-Wen Sun, He Su, Quan Chen, Tian-Kang Guo, Yuan Li, Xiao-Chang Chen, Jin Guo, Zhen-Qiang Gong, Xiao-Dan Zhao & Jian-Bo Qi. (2017) Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer. World Journal of Gastroenterology 23:28, pages 5167.
Crossref
Crossref
Suliman A. Alsagaby, Paul Brennan & Chris Pepper. (2016) Key Molecular Drivers of Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 16:11, pages 593-606.
Crossref
Crossref
Guo-Zheng Pan, Feng-Xian Zhai, Yin Lu, Zhi-Gang Fang, Rui-Fang Fan, Xiang-Fu Liu & Dong-Jun Lin. (2016) RUNX3 plays an important role in As2O3-induced apoptosis and allows cells to overcome MSC-mediated drug resistance. Oncology Reports 36:4, pages 1927-1938.
Crossref
Crossref
Irene Amigo-Jiménez, Elvira Bailón, Noemí Aguilera-Montilla, María José Terol, José A. García-Marco & Angeles García-Pardo. (2015) Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Oncotarget 6:42, pages 44832-44848.
Crossref
Crossref
Alessio Montresor, Lara Toffali, Michela Mirenda, Antonella Rigo, Fabrizio Vinante & Carlo Laudanna. (2015) JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia. Oncotarget 6:33, pages 34245-34257.
Crossref
Crossref
QUANCHI CHEN, WEI SUN, YUXIN LIAO, HUI ZENG, LIANCHENG SHAN, FEI YIN, ZHUOYING WANG, ZIFEI ZHOU, YINGQI HUA & ZHENGDONG CAI. (2015) Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT. Molecular Medicine Reports 12:1, pages 219-225.
Crossref
Crossref
Vanessa L Bryant & Charlotte A Slade. (2015) Chemokines, their receptors and human disease: the good, the bad and the itchy. Immunology & Cell Biology 93:4, pages 364-371.
Crossref
Crossref
Miao Mo, Mi Zhou, Lu Wang, Lin Qi, Kehua Zhou, Long-Fei Liu, Zhi Chen & Xiong-Bing Zu. (2015) CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells. PLOS ONE 10:3, pages e0119506.
Crossref
Crossref
Gregor Hoermann, Georg Greiner & Peter Valent. (2015) Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms. Mediators of Inflammation 2015, pages 1-17.
Crossref
Crossref
Jean-François Rossi. (2015) Targeted Therapies in Adult B-Cell Malignancies. BioMed Research International 2015, pages 1-16.
Crossref
Crossref
Ajay Palagani, Ken Op de Beeck, Stefan Naulaerts, Jolien Diddens, Chandra Sekhar Chirumamilla, Guy Van Camp, Kris Laukens, Karen Heyninck, Sarah Gerlo, Pieter Mestdagh, Joke Vandesompele & Wim Vanden Berghe. (2014) Ectopic MicroRNA-150-5p Transcription Sensitizes Glucocorticoid Therapy Response in MM1S Multiple Myeloma Cells but Fails to Overcome Hormone Therapy Resistance in MM1R Cells. PLoS ONE 9:12, pages e113842.
Crossref
Crossref